The incidence of Human Papillomavirus (HPV)–associated oropharyngeal cancers—tumors of the back of the mouth and throat—is ...

Roche’s Genentech is betting on the Flagship Pioneering–founded company’s discovery platform called DECODE to find new ...

The precise use of immunotherapy agents in locally advanced head and neck squamous cell carcinoma has not been clearly ...

Roche’s Genentech has inked a deal with Repertoire Immune Medicines aimed at discovering and developing T-cell-targeted ...

2 Human immunodeficiency virus (HIV) is also an immune modulating disease in consideration for its association with HS and HPV. The data indicated that HIV-positive individuals in the HPV group ...

HPV is fuelling high cervical cancer rates in sub-Saharan Africa despite the availability of effective vaccines. Yet uptake remains l ...

Those two are the most important risk factors for the development of head and neck cancer, and a patient can be HPV-positive in their tumor and a smoker at the same time, so they are not mutually ...

Pap tests and HPV testing are a vital part of women's health care, but many people dread the invasive examination every three years. For some women, particularly sexual violence survivors ...

LUXEMBOURG, LUXEMBOURG, April 22, 2025 /EINPresswire.com/ -- Advanced Biological Laboratories (ABL), a diagnostics company, headquartered in Luxembourg, is pleased to ...

Glenn Moog didn't know much about HPV cancer — until he was diagnosed with it. The 59-year-old husband, father and realtor from Worthington had a swollen lymph node on his neck that kept getting ...

The reported noted that the decrease is alarming as HPV vaccination rates have remained “statistically unchanged” in recent years. In 2023, 61.4% of adolescents ages 13 to 17 were up-to-date ...

The incidence of Human Papillomavirus (HPV)-associated oropharyngeal cancer tumors of the back of the mouth and throat is rising. If caught early, ...